Real-world survival outcomes in first-line ibrutinib-treated patients with high-risk CLL/SLL

Real-world survival outcomes in first-line ibrutinib-treated patients with high-risk CLL/SLL

Abstract: In patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), high-risk cytogenetic features such as del(17p), del(11q), and unmutated immunoglobulin variable heavy chain (IGHV) may be associated with unfavorable outcomes. In this large retrospective cohort study, d...

Full description

Saved in:
Bibliographic Details
Main Authors: John N. Allan, Tao Ran, Zhijie Ding, Jinghua He, Alex Bokun, Zaina P. Qureshi, Susan M. O’Brien
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2473952925002848
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items